期刊文献+

2型糖尿病患者血清戊糖素与骨转换指标之间的相关性分析

The relationship between the serum pentosidine and boner turnover markers in patients with type 2 diabetes
下载PDF
导出
摘要 目的探讨在2型糖尿病患者中血清戊糖素水平与骨转换指标之间的相关性以了解戊糖素对骨代谢的影响。方法190例绝经后女性及>60岁男性2型糖尿病患者于空腹状态下抽取空腹静脉血液查肝肾功能、糖化血红蛋白(Hb A1C)、I型胶原羧基端肽β特殊序列(β-CTX)、I型前胶原氨基端前肽(PINP)、骨钙素(OC)及戊糖素水平,分析戊糖素与肝肾功能及骨转换指标之间的相关性。结果相关分析结果提示戊糖素与糖尿病病程、Hb A1c、β-CTX水平相关(r=0.492、0.158和-0.156,P均<0.05),而与PINP及OC之间的相关性无统计学意义(P=0.646和0.72)。多元线性回归分析结果提示戊糖素水平与糖尿病病程、Hb A1C相关(P均<0.05),而与β-CTX的相关性无统计学意义(P=0.199)。结论 2型糖尿病患者血戊糖素水平与骨转换指标PINP、β-CTX及OC水平之间无明显的相关性。 Objective To investigate the relationship between serum pentosidine and boner turnover markers in patients with type 2 diabetes mellitus (T2DM). Methods One hundred and ninety postmenopausal women and over 60 years old men with T2DM were enrolled. Fasting blood was withdrawn. The hemoglobin Alc (HbA1c ) , C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptides of type I procollagen (PINP) , osteocalcin (OC) , and serum pentosidine were determined. The relationship between pentosidine and liver and kidney function and bone turn markers was analyzed. Results The serum penotosidine levels were positively correlated with the duration of T2DM ( r = 0. 492, P 〈 0. 05 ) and HbAlc ( r = 0. 158, P 〈 0. 05 ), but negatively correlated with β-CTX ( r = - 0. 156, P 〈 0. 05 ). Multiple linear regression analysis showed that the duration of the T2DM and HbAlc were associated with the serum pentosidine levels but were not associated with β-CTX. Conclusion The serum penotosidine level is not related to bone turnover markers in T2DM patients.
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2015年第10期1240-1243,共4页 Chinese Journal of Osteoporosis
基金 新乡市重点科技攻关计划项目(ZG13028)
关键词 2型糖尿病 戊糖素 骨转换指标 Type 2 diabetes Pentosidine Bone turnover markers
  • 相关文献

参考文献12

  • 1Lili M, Ling O, Lindi J, et al. Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol, 2012,27 (5) :319-332.
  • 2Peter J ,Juraj P. Osteoporosis, Fractures, and Diabetes. Int J Endocrinol, 2014 ,2014:820615.
  • 3Roberta S, Alessandra P, Francois M,et al. Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis. Mediators Inflamm, 2014,2014 : 975872.
  • 4Hein G, Weiss C, Lehmann G, et al. Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis, 2006 ,65(1) : 101-104.
  • 5Yamamoto M, Yamaguchi T, Yamauchi M, et al. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab ,2008,93 (3) : 1013-1019.
  • 6Sanguineti R, Storace D, Monaeelli F, et al. Pentosidine effects on human osteoblasts in vitro. Ann N Y Aead Sci,2008,1126: 166-172.
  • 7Miyata T, Notoya K, Yoshida K, et al. Advanced glycation end products enhance osteoclast induced bone resorption in cultured unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol, 1997, 8(2) : 260-270.
  • 8Odetti P, Rossi S, Monacelli F, et al. Advanced glycation end products and bone loss during aging. Ann NY Acad Sci, 2005, 1043:710-717.
  • 9Saito M, Fujii K, Mori Y, et al. Role of collagen enzymatic and glyeation induced cross-links as a determinant of bone qualityin spontaneously diabetic WBN/Kob rats. Osteoporos Int, 2006,17 (10) : 1514-1523.
  • 10Viguet-Carrin S, Garnero P, Delmas PD. The role of collagen in bone strength. Osteoporos Int,2006,17 ( 3 ) :319-336.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部